XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Equity (Deficit) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Warrants
Additional Paid-In- Capital
Accumulated Deficit
Non- Controlling Interest
Beginning balance (in shares) at Dec. 26, 2021   28,380          
Beginning balance at Dec. 26, 2021 $ (2,417) $ 380 $ (114,577) $ 2,566 $ 452,570 $ (343,261) $ (95)
Net income (7,887)         (7,913) 26
Shares issued under equity compensation plan (in shares)   81          
Shares issued under equity compensation plan (278) $ 1 (279)        
Distributions to non-controlling interest (120)           (120)
Stock-based compensation expense 675       675    
Ending balance (in shares) at Mar. 27, 2022   28,461          
Ending balance at Mar. 27, 2022 (10,027) $ 381 (114,856) 2,566 453,245 (351,174) (189)
Beginning balance (in shares) at Dec. 26, 2021   28,380          
Beginning balance at Dec. 26, 2021 (2,417) $ 380 (114,577) 2,566 452,570 (343,261) (95)
Net income 1,957            
Ending balance (in shares) at Sep. 25, 2022   28,791          
Ending balance at Sep. 25, 2022 909 $ 384 (115,331) 2,566 455,012 (341,571) (151)
Beginning balance (in shares) at Mar. 27, 2022   28,461          
Beginning balance at Mar. 27, 2022 (10,027) $ 381 (114,856) 2,566 453,245 (351,174) (189)
Net income 708         574 134
Shares issued under equity compensation plan (in shares)   235          
Shares issued under equity compensation plan (326) $ 2 (325)   (3)    
Distributions to non-controlling interest (56)           (56)
Stock-based compensation expense 820       820    
Ending balance (in shares) at Jun. 26, 2022   28,696          
Ending balance at Jun. 26, 2022 (8,881) $ 383 (115,181) 2,566 454,062 (350,600) (111)
Net income 9,136         9,029 107
Shares issued under equity compensation plan (in shares)   95          
Shares issued under equity compensation plan (150) $ 1 (150)   (1)    
Distributions to non-controlling interest (147)           (147)
Stock-based compensation expense 951       951    
Ending balance (in shares) at Sep. 25, 2022   28,791          
Ending balance at Sep. 25, 2022 $ 909 $ 384 (115,331) 2,566 455,012 (341,571) (151)
Beginning balance (in shares) at Dec. 25, 2022 28,819 28,819          
Beginning balance at Dec. 25, 2022 $ 4,273 $ 384 (115,388) 2,566 455,831 (338,916) (204)
Net income (1,204)         (1,327) 123
Shares issued under equity compensation plan (in shares)   70          
Shares issued under equity compensation plan (337) $ 1 (337)   (1)    
Distributions to non-controlling interest (152)           (152)
Issuance of common shares and warrants, net of fees (in shares)   159          
Proceeds from exercise of warrants 865 $ 1   (313) 1,177    
Stock-based compensation expense 911       911    
Ending balance (in shares) at Mar. 26, 2023   29,048          
Ending balance at Mar. 26, 2023 $ 4,356 $ 386 (115,725) 2,253 457,918 (340,243) (233)
Beginning balance (in shares) at Dec. 25, 2022 28,819 28,819          
Beginning balance at Dec. 25, 2022 $ 4,273 $ 384 (115,388) 2,566 455,831 (338,916) (204)
Net income $ 2,825            
Ending balance (in shares) at Sep. 24, 2023 29,350 29,350          
Ending balance at Sep. 24, 2023 $ 9,659 $ 389 (116,638) 2,219 460,543 (336,532) (322)
Beginning balance (in shares) at Mar. 26, 2023   29,048          
Beginning balance at Mar. 26, 2023 4,356 $ 386 (115,725) 2,253 457,918 (340,243) (233)
Net income 2,381         2,216 165
Shares issued under equity compensation plan (in shares)   243          
Shares issued under equity compensation plan (771) $ 3 (772)   (2)    
Distributions to non-controlling interest (166)           (166)
Issuance of common shares and warrants, net of fees (in shares)   18          
Proceeds from exercise of warrants 96     (34) 130    
Stock-based compensation expense 1,305       1,305    
Ending balance (in shares) at Jun. 25, 2023   29,309          
Ending balance at Jun. 25, 2023 7,201 $ 389 (116,497) 2,219 459,351 (338,027) (234)
Net income 1,649         1,495 154
Shares issued under equity compensation plan (in shares)   41          
Shares issued under equity compensation plan (141) $ 0 (141)   0    
Distributions to non-controlling interest (242)           (242)
Issuance of common shares and warrants, net of fees (in shares)   0          
Proceeds from exercise of warrants 0     0 0    
Stock-based compensation expense $ 1,192       1,192    
Ending balance (in shares) at Sep. 24, 2023 29,350 29,350          
Ending balance at Sep. 24, 2023 $ 9,659 $ 389 $ (116,638) $ 2,219 $ 460,543 $ (336,532) $ (322)